In current practice, gadolinium-based contrast agents have been considered safe when
used at clinically recommended doses in patients without severe renal insufficiency. The …

In 1988, the first contrast agent specifically designed for magnetic resonance imaging (MRI),
gadopentetate dimeglumine (Magnevist®), became available for clinical use. Since then, a …

Computer-aided image analysis for better understanding of images has been time-honored
approaches in the medical computing field. In the conventional machine learning approach …

Owing to their unique physical and chemical properties, magnetic iron oxide nanoparticles
have become a powerful platform in many diverse aspects of biomedicine, including …

Hepatic cancer is a serious disease with high morbidity and mortality. Theranostic agents
with effective diagnostic and therapeutic capability are highly needed for the treatment of …

Purpose Mammography, the standard method of breast cancer screening, misses many
cancers, especially in dense-breasted women. We compared the performance and …

Since the 1980s, gadolinium (Gd)–based contrast agents (GBCAs) have been routinely
used in magnetic resonance imaging as stable chelates of the Gd3+ ion, without toxic …

Magnetic resonance imaging (MRI) contrast agents are pharmaceuticals used widely in MRI
examinations. Gadolinium‐based MRI contrast agents (GBCAs) are by far the most …

Purpose To determine if a correlation exists between the number of previous enhanced
magnetic resonance (MR) imaging examinations and high signal intensity in the globus …

Magnetic resonance imaging is a commonly used diagnostic method in medicinal practice
as well as in biological and preclinical research. Contrast agents (CAs), which are often …